Clinical Trial Update: 68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 68Ga-NY104 PET/CT for suspected metastasis/recurrence of clear cell renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• 68Ga-NY104 (Gallium-68 NY104 PET tracer)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Clear Cell Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN